These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 4592603)

  • 1. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes.
    Chess L; Rocklin RE; MacDermott RP; David JR; Schlossman SF
    J Immunol; 1975 Jul; 115(1):315-7. PubMed ID: 50357
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages.
    Petty HR; Ware BR; Remold HG; Rocklin RE
    J Immunol; 1980 Jan; 124(1):381-7. PubMed ID: 6153099
    [No Abstract]   [Full Text] [Related]  

  • 5. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Migration inhibitory test and its clinical aspects].
    Dobozy A; Hunyadi J; Simon N
    Berufsdermatosen; 1973 Aug; 21(4):137-51. PubMed ID: 4583667
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of migration inhibition tests in penicillin hypersensitivity.
    Warrington RJ; Sauder PJ; Rutherford WJ
    Clin Exp Immunol; 1979 Oct; 38(1):148-57. PubMed ID: 393437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor.
    Pick E; Godny Y; Gold EF
    Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of mononuclear phagocytes in vitro: immunologically mediated enhancement.
    Adams DO; Biesecker JL; Koss LG
    J Reticuloendothel Soc; 1973 Dec; 14(6):550-70. PubMed ID: 4204505
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 13. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of migration inhibitory factor and lymphotoxin by non-T cells.
    Bloom BR; Stoner G; Gaffney J; Shevach E; Green I
    Eur J Immunol; 1975 Mar; 5(3):218-20. PubMed ID: 789088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
    Remold HG; David RA; David JR
    J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
    [No Abstract]   [Full Text] [Related]  

  • 16. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
    Matsui Y; Oshima S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The migration of guinea-pig macrophages in the presence of tuberculin-sensitive mouse lymphocytes and tuberculin.
    Lo ST; Han SH
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1972 Jun; 5(1):87-8. PubMed ID: 4598542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.